Structural basis of μ-opioid receptor targeting by a nanobody antagonist

17

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

Tags:

Previous Article

How Chlamydia manipulate the host cell

Tiny antibodies to fight the dangerous effects of opioids

Related Posts

Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)

Lipotoxicity-driven metabolic dysfunction-associated st...

34

Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer

Peripheral, central, and chemotherapy-induced neuropath...

31

Restricting lysine normalizes toxic catabolites associated with ALDH7A1 deficiency in cells and mice

Restricting lysine normalizes toxic catabolites associa...

35